This inventor holds 2 USPTO granted patents. Top assignee: University of California. Active years: 2004-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2006
Title: Israel R Charo: Innovator in Chemokine Receptor Research
Introduction
Israel R Charo is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of biochemistry, particularly in the study of chemokine receptors. With a total of 2 patents, his work has implications for therapeutic advancements in various diseases.
Latest Patents
Charo's latest patents focus on MCP-1 receptor antibodies, specifically the novel human chemokine receptors MCP-1RA and MCP-1RB. These patents disclose processes for producing these receptors, which are alternately spliced versions of the MCP-1 receptor protein. The receptors may be utilized in assays to identify antagonists of MCP-1, which are therapeutically useful in treating atherosclerosis and other diseases characterized by monocytic infiltrates.
Career Highlights
Israel R Charo is affiliated with the University of California, where he conducts his research. His work has garnered attention for its potential to influence treatment strategies for diseases linked to immune responses.
Collaborations
One of Charo's notable collaborators is Shaun R Coughlin, with whom he has worked on various research projects related to chemokine receptors.
Conclusion
Israel R Charo's innovative research in chemokine receptors positions him as a key figure in the development of new therapeutic approaches. His contributions continue to advance our understanding of immune-related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile